DWA
XBI icon

Dorsey Wright & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dorsey Wright & Associates’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,540
Closed -$301K – 145
2017
Q4 		$301K Sell
3,540
-233
-6% -$19.5K 0.05% 134
2017
Q3 		$327K Buy
+3,773
New +$302K 0.08% 133

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Dorsey Wright & Associates's XBI Position: Q1 2018 in Review

Dorsey Wright & Associates sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2018, closing a stake of 3,540 shares — an estimated $301K sold.

Dorsey Wright & Associates first reported a position in XBI in Q3 2017 and held it in 2 quarters. The position peaked at $327K in Q3 2017. 414 funds tracked by Wall St. Rank hold XBI as of Q1 2018.

  • Dorsey Wright & Associates reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2018 after selling out during the quarter.
  • Dorsey Wright & Associates sold 3,540 State Street SPDR S&P Biotech ETF shares in Q1 2018, an estimated $301K.
  • Dorsey Wright & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and held it in 2 quarters.
  • Dorsey Wright & Associates's State Street SPDR S&P Biotech ETF position peaked at $327K in Q3 2017.
  • 414 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2018.

Based on Dorsey Wright & Associates's 13F filing for Q1 2018, filed 30 Apr 2018.